1. Home
  2. PZZA vs ABCL Comparison

PZZA vs ABCL Comparison

Compare PZZA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$34.80

Market Cap

1.2B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
ABCL
Founded
1984
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
PZZA
ABCL
Price
$34.80
$4.60
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$45.00
$8.40
AVG Volume (30 Days)
665.1K
5.3M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
10.91
EPS
0.90
N/A
Revenue
$2,068,421,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$21.85
P/E Ratio
$39.59
N/A
Revenue Growth
14.07
160.56
52 Week Low
$30.16
$1.94
52 Week High
$55.74
$6.52

Technical Indicators

Market Signals
Indicator
PZZA
ABCL
Relative Strength Index (RSI) 45.02 70.60
Support Level $30.47 $3.93
Resistance Level $34.89 $4.84
Average True Range (ATR) 1.41 0.26
MACD -0.29 0.05
Stochastic Oscillator 9.04 89.30

Price Performance

Historical Comparison
PZZA
ABCL

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: